Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,949 | 335,816 | 89,966 | 120,256 | 110,718 |
| Marketable Securities | 392,733 | 329,629 | 373,184 | 368,488 | 439,252 |
| Receivables | N/A | 40,000 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 20,000 | 947 | 1,317 |
| TOTAL | $528,298 | $728,327 | $500,951 | $510,268 | $568,715 |
| Non-Current Assets | |||||
| PPE Net | 45,128 | 48,572 | 49,172 | 50,457 | 51,244 |
| Investments And Advances | 473,055 | 297,629 | 312,335 | 362,159 | 361,035 |
| Other Non-Current Assets | 55,563 | 56,540 | 55,854 | 55,151 | 53,848 |
| TOTAL | $573,746 | $402,741 | $417,361 | $467,767 | $466,127 |
| Total Assets | $1,102,044 | $1,131,068 | $918,312 | $978,035 | $1,034,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,506 | 5,781 | 10,263 | 5,989 | 6,494 |
| Accrued Expenses | 28,639 | 27,976 | 23,117 | 34,867 | 26,530 |
| Other current liabilities | 408 | 117 | 893 | 223 | 633 |
| TOTAL | $71,575 | $87,540 | $58,989 | $67,767 | $66,532 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,279 | 40,000 | 11,476 | 13,576 | 20,024 |
| Other Non-Current Liabilities | 68,450 | 69,835 | 71,182 | 72,423 | 73,636 |
| TOTAL | $84,211 | $72,048 | $73,090 | $74,649 | $75,380 |
| Total Liabilities | $155,786 | $159,588 | $132,079 | $142,416 | $141,912 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,949 | 71,498 | 65,120 | 64,944 | 64,765 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -978,980 | -896,805 | -820,191 | -754,610 | -683,858 |
| Other shareholders' equity | 1,501 | 279 | -58 | -1,485 | 1,931 |
| TOTAL | $946,258 | $971,480 | $786,233 | $835,619 | $892,930 |
| Total Liabilities And Equity | $1,102,044 | $1,131,068 | $918,312 | $978,035 | $1,034,842 |